---
title: "Naltrexone - Obesity"
sidebar: mydoc_sidebar
permalink: db00704-mesh-d009765-1.html
toc: false 
---


Path ID: `DB00704_MESH_D009765_1`
{% include image.html url="images/db00704-mesh-d009765-1.png" file="db00704-mesh-d009765-1.png" alt="db00704-mesh-d009765-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D009270">MESH:D009270 </a> | Naltrexone | Drug |
| <a href="https://identifiers.org/MESH:D009765">MESH:D009765 </a> | Obesity | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Naltrexone | TREATS | Obesity |
|---------|-----------|---------|

Comment: Naltrexone is associated with minimal weight loss as monotherapy, but has potential utility in the treatment of obesity when combined with Pro-opiomelanocortin activator - bupropion.

Reference: 
  - [https://go.drugbank.com/drugs/DB00704](https://go.drugbank.com/drugs/DB00704)
  - [https://pubmed.ncbi.nlm.nih.gov/19537999/](https://pubmed.ncbi.nlm.nih.gov/19537999/)
